Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA) Patients were randomly assigned to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback